Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. 

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Small Grants for Behavioral Research in Cancer Control (R03).                     

*Date:*                         June 7, 2012.                     

*Time:*                         8:30 a.m. to 4 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.                     

*Contact Person:*                        Ellen K Schwartz, EDD, MBA, Scientific Review Officer,Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,                         *schwarel@mail.nih.gov*.                     

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovative Molecular Analysis Technologies for Cancer (R21).                     

*Date:*                         June 26-27, 2012.                     

*Time:*                         8 a.m. to 6 p.m.                     

*Agenda:*                         To review and evaluate grant applications and/or proposals.                     

*Place:*                         Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.                     

*Contact Person:*                        Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard Room 8059, Bethesda, MD 20892-8329, 301-496-7904,                         *decluej@mail.nih.gov.*

                        Information is also available on the Institute's/Center's home page:                         *http://deainfo.nci.nih.gov/​advisory/​sep/​sep.htm*, where an agenda and any additional information for the meeting will be posted when available.                     

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: March 27, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2012-7824 Filed 3-30-12; 8:45 am] 

BILLING CODE 4140-01-P